[뉴욕=뉴스핌]Correspondent Geun-cheol Kim = The U.S. Food and Drug Administration (FDA) approved on the 3rd (local time) that Pfizer and Moderna’s booster shot (boost shot) targets should be expanded to 12 years of age and older.
According to major foreign media such as Archyde.com, in a statement on the same day, the FDA approved Pfizer and Moderna’s COVID-19 vaccine booster shot to be administered to those aged 15 and older to those aged 12 and older. The FDA also announced that booster shots of these vaccines can be given to children aged 5 to 11 with compromised immunity.
This decision was made amid the explosive spread of COVID-19 in the United States and around the world.
The FDA said, “After reviewing the latest available data, the current booster shots will help provide better protection once morest delta and omicron mutations,” said the FDA. As a result of the study, it was revealed that no adverse events such as rare myocarditis have been reported so far.
In addition, the FDA said that the previous two doses of vaccination may not be effective for Omicron. he added that he might.
| Moderna and Pfizer’s COVID-19 vaccine. [사진=로이터 뉴스핌] |